FTRE as of Nov 5 · 09:34 ET
FTRENasdaqServices-Medical Laboratories
Fortrea Holdings Inc. · Brief
Next report
112 days
Feb 25 · before openest.Q4 FY26
Expected move
No implied move.
3 of 7≥ implied
- avg implied
- ±19.0%
- avg realized
- ±14.0%
Mar 3 '25±19.1%▼−25.05%×1.31
May 12 '25±20.9%▼−15.61%×0.75
Aug 6 '25±17.4%▲+0.30%×0.02
Nov 5 '25±19.1%▲+23.20%×1.21
Q1 FY26±22.3%▲+4.45%×0.20
May 5 '26±16.6%▲+18.61%×1.12
Q2 FY26—▼−1.45%—
Q3 FY26±17.7%▼−10.61%×0.60
quarterimplied−30%0+30%realized×
Q3 FY26±17.7%▼−10.61%×0.60
Q2 FY26—▼−1.45%—
May '26±16.6%▲+18.61%×1.12
Q1 FY26±22.3%▲+4.45%×0.20
Nov '25±19.1%▲+23.20%×1.21
Aug '25±17.4%▲+0.30%×0.02
2 older reports
May '25±20.9%▼−15.61%×0.75
Mar '25±19.1%▼−25.05%×1.31
Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close
Bull & bear
Feb 25 report · est.Bull2 of 3
Bear2 of 4
AI captions · Nov 2 '26once per report · top 2 per case
Linked exposure
FTRE report sessionSuppliers 1
× = co-movement · max 500dSource: SEC filings · market data
Your note
privateThesis 0 · Decisions 0 · Observations 0
No thesis.